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Impact on malaria morbidity of a programme supplying
insecticide treated nets in children aged under 2 years in
Tanzania: community cross sectional study
Salim Abdulla, Joanna Armstrong Schellenberg, Rose Nathan, Oscar Mukasa, Tanya Marchant,
Tom Smith, Marcel Tanner, Christian Lengeler
Abstract
Objective To assess the impact of a social marketing
programme for distributing nets treated with
insecticide on malarial parasitaemia and anaemia in
very young children in an area of high malaria
transmission.
Design Community cross sectional study. Annual,
cross sectional data were collected at the beginning of
the social marketing campaign (1997) and the
subsequent two years. Net ownership and other risk
and confounding factors were assessed with a
questionnaire. Blood samples were taken from the
children to assess prevalence of parasitaemia and
haemoglobin levels.
Setting 18 villages in the Kilombero and Ulanga
districts of southwestern Tanzania.
Participants A random sample of children aged
under 2 years.
Main outcome measures The presence of any
parasitaemia in the peripheral blood sample and the
presence of anaemia (classified as a haemoglobin level
of < 80 g/l).
Results Ownership of nets increased rapidly (treated
or not treated nets: from 58% to 83%; treated nets:
from 10% to 61%). The mean haemoglobin level rose
from 80 g/l to 89 g/l in the study children in the
successive surveys. Overall, the prevalence of anaemia
in the study population decreased from 49% to 26%
in the two years studied. Treated nets had a protective
efficacy of 62% (95% confidence interval 38% to 77%)
on the prevalence of parasitaemia and of 63% (27% to
82%) on anaemia.
Conclusions These results show that nets treated with
insecticide have a substantial impact on morbidity
when distributed in a public health setting.
Introduction
Several studies have shown that malarial parasitaemia
is positively correlated with anaemia and that
parasitaemia is the primary cause of anaemia in very
young children in Africa.1 As a result, because malarial
infection is the norm in high transmission areas, anae›
mia is common in young children. Assessment of the
impact of chemoprophylaxis in Tanzanian infants
showed that over 60% of the anaemia could be due to
malaria.2 The emergence and spread of parasite resist›
ance to commonly used antimalarial agents has
exacerbated the problem of anaemia in sub›Saharan
Africa.3
Hopes for controlling malaria and malarial
anaemia have recently been revitalised by the demon›
stration that nets treated with insecticide can reduce
morbidity and mortality. A summary of randomised
controlled trials showed an average protective effect of
about 50% on mild malaria episodes in areas where the
rate of transmission of malaria was stable.4 Moreover,
protective effects were shown on the prevalence of
parasitaemia with a high level ( > 5000/ìl) of
trophozoites (31%) and on overall mortality (19%). A
modest improvement in packed cell volume (a rise of
0.02 (2%)) and weight gain was also observed in
children sleeping under treated nets.4 Large scale
implementation of programmes to supply treated nets
is under way in several African countries.5
It is not known whether the impact of treated nets
in the context of well controlled randomised
controlled trials can be replicated under programme
conditions.6 We report the first assessment of the
impact of treated bed nets when supplied in the
context of a large scale social marketing programme
(an approach using marketing techniques to promote
and distribute socially beneficial interventions rather
than commercial products) on morbidity indicators in
children aged under 2 years in an area of Tanzania with
a high prevalence of malaria.
Methods
Study area and population
Social marketing of treated bed nets started in the
Kilombero net project (KINET) in 1997,7 covering the
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Kilombero and Ulanga districts (population 350 000)
in southwestern Tanzania. Nets and insecticide
(branded Zuia Mbu) are now being promoted,
distributed, and sold through public and private outlets
and a system of community door to door distributors.
When the project began, the retail price of a treated net
was $5 (£3.60). Although this amount was not a negli›
gible part of the average annual income in this
community, many of the residents bought a net.7 The
impact of the programme on morbidity and mortality
indicators is being monitored in 18 villages under
demographic surveillance. Population characteristics
of this area of high perennial malaria transmission
have been described elsewhere.8 Moderate anaemia
(packed cell volume < 0.25 (< 25%)) and severe
anaemia occur in 61% and 14% respectively of
children aged under 5 years who are admitted to the
local St Francis District Hospital.9 Resistance to chloro›
quine is common: 65% of malaria infections do not
clear within one week of chloroquine treatment.10
Design
Three annual, cross sectional surveys were conducted
in a sample of children aged under 2 years living in the
villages in the demographic surveillance area.7 The first
survey was done at the time of launching the social
marketing campaign in June 1997, and two other sur›
veys were carried out at the same period (June to
August) in the subsequent two years. A simple random
sample was selected from the demographic surveil›
lance database for the first survey, and a two stage, ran›
dom sampling (of six villages then sampling children
from these) was done for the subsequent surveys. A dif›
ferent sample was selected for each survey.
We obtained ethical approval for the study from the
Ifakara Health Research and Development Centre and
the Tanzania Commission of Science and Technology.
Procedures
The selected children were visited at home, and oral
consent obtained from the parent or guardian. A ques›
tionnaire was used to assess use of treated nets and
other potential risk factors. A physical examination was
performed, and temperature, weight, and height were
also measured. A finger prick blood sample was taken
to determine haemoglobin level and assess whether
parasitaemia was present. Haemoglobin levels were
measured with a portable kit, HemoCue (HemoCue,
˜ngelholm, Sweden). Slides were stained in Giemsa
and were read (without the microscopists knowing the
child’s net status) using standard procedures as
described elsewhere.9 An inspection of the children’s
sleeping places to assess their use of nets was done only
in 1999 because this was strongly perceived as an
intrusion of their privacy.
Anaemia was classified as a haemoglobin level of
(< 80 g/l) as this is the level that has been associated
with increased mortality11 and is consistent with earlier
studies in Tanzania.2 Parasitaemia and splenomegaly
were classified as either present or absent. Use of
treated nets was categorised on the basis of the
respondents’ answers on ownership and if the nets
were “ever treated” or “not treated.” No simple field
methods exist for assessing insecticide content in nets.
Data analysis
Analysis was done for the three cross sectional surveys
combined. We estimated impact of the nets on haemo›
globin level, anaemia, parasitaemia, and splenomegaly
using multiple linear and logistic regression models,
taking into account the sampling methods for years 2
and 3, and using robust regression approaches in
STATA software.12 We included the effect of different
time points of observation (surveys) as one of the
explanatory variables.
We also included in the multivariate models the use
of a net, condition of the net, age, sex, ethnicity,
religion, nutritional status, and access to a dispensary,
shops, and covered wells. Treatment history and
“health seeking” attitudes were also included, as were
factors related to family size and income.
Results
We identified 985 eligible children; the mothers of 16
of these children refused consent, and 142 mothers
could not be traced at their homes. Therefore, mothers
(or guardians) of 827 children were interviewed during
the three cross sectional surveys. Sixty eight children
were over 24 months old at the time of sampling, and
the net status was not known for 11 children; therefore
only 748 (91%) children were included in the analysis.
Similar proportions of anaemia and of reported net
ownership were found in the children analysed and
those not analysed (data not shown).
We observed an increase in the mean haemoglobin
level from 80 g/l to 89 g/l and a decline in the
proportion of children with anaemia (49% to 26%),
parasitaemia (63% to 38%), and splenomegaly (86% to
49%) during the successive surveys (table 1). The
proportion of children with a net (treated or untreated)
increased from 58% (140/240) to 83% (199/239), and
those with treated nets increased substantially during
the three years (from 10% to 61%), indicating a rapid
uptake of the socially marketed treated nets, especially
during the first year (table 1).
Ownership and use of nets
Predictors of net ownership included family income:
families with a high income (highest quarter) were
almost three times more likely to have a bed net than
those with a low income (lowest quarter) (table 2). This
Table 1 Characteristics of children surveyed in three cross sectional surveys, 1997›9.
Values are numbers (percentages) of children unless stated otherwise
Year 1997 1998 1999 Overall
Eligible 325 330 330 985
Interviewed 269 (83) 291 (88) 267 (81) 827 (84)
Analysed 240 (74) 269 (82) 239 (72) 748 (76)
Children analysed
Mean (range) age (months) 14.2 (3.3›26.4) 13.5 (3.0›24.7) 15.4 (2.4›25.5) 14.4 (2.4›26.4)
Male 122 (51) 137 (51) 113 (47) 372 (50)
Mean (SE) haemoglobin (g/l) 80 (1.2) 89 (1.0) 89 (1.0) 86 (0.7)
Children with anaemia
(haemoglobin <80 g/l)
118 (49) 83 (31) 62 (26) 263 (35)
Children with parasitaemia 151 (63) 126 (47) 90 (38) 367 (49)
Children with splenomegaly 207 (86) 144 (54) 117 (49) 468 (63)
Reported net ownership:
No net 100 (42) 49 (18) 40 (17) 189 (25)
Untreated net 116 (48) 64 (24) 53 (22) 233 (31)
Treated net 24 (10) 156 (58) 146 (61) 326 (44)
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was expected as the treated nets were being sold. By the
end of the second year of the marketing campaign
(1999), only 17% of the children were without a net.
Children with no access to covered wells (piped clean
water)—that is, not at the centre of the villages—were less
likely to have nets (table 2). Mothers who mentioned that
they would advise their neighbours to send their sick
children to a formal health facility were more likely to
have nets for their own children (odds ratio 2.27;
likelihood ratio test ÷2 = 3.90, P value = 0.048) than
mothers who advised care by a traditional healer. This
might reflect an association between health seeking pat›
terns or perceptions about the value of the formal health
system and the decision to have a net or not.
Observation of sleeping places for 171 children in
1999 showed that 117 of the 126 (93%) mothers who
claimed to be using nets had a net hanging at the
sleeping place. For all nine children who had a missing
net at the sleeping place, we were shown a net claimed
to be used. Among those who claimed not to be using
nets, 17% (8/45) had a net hanging at the sleeping
place. Eight of the 45 (17%) mothers who claimed not
to be using nets had a net hanging at the sleeping
place. These observations showed that reported
ownership and reported use provided a reasonable
basis for defining net status.
Health impact of treated nets
We observed a protective efficacy—defined as (1 − odds
ratio) × 100—on the prevalence of parasitaemia of 62%
(95% confidence interval 38% to 77%) and 51% (0% to
76%) for treated and untreated nets respectively, when
compared with children without nets (table 3). The
prevalence of parasitaemia was also related to ethnic
group, religion, use of the net in the previous month,
and age of the child, with the prevalence in those aged
over 1 year being four times higher than that in those
aged under 7 months (table 3). This is consistent with
earlier studies in Tanzania that showed that prevalence
of parasitaemia increased with age.13 14
The mean haemoglobin level was 77 g/l (95% con›
fidence interval 74 g/l to 79 g/l) in children without
nets, 86 g/l (83 g/l to 88 g/l) in those with untreated
nets, and 92 g/l (90 g/l to 93 g/l) in those with treated
nets. Multiple regression analysis showed that haemo›
globin level increased by 13 g/l (8 g/l to 17 g/l) in
those with treated nets and by 11 g/l (5 g/l to 17 g/l) in
those with untreated nets, compared with those with
no nets. On the basis of our classification of anaemia,
a protective efficacy of 37% ( − 46% to 73%) for un›
treated nets and 63% (27% to 82%) for treated nets was
observed. Children whose height was stunted or who
had no access to covered wells were more likely to be
anaemic (table 4). If the cut›off level for anaemia was
set at 110 g/l, the protective efficacy of untreated nets
was 78% (29% to 93%) and of treated nets was 82%
(42% to 94%). Parasitaemia was associated with
anaemia: children with severe parasitaemia had lower
mean haemoglobin levels than those with no or mild
parasitaemia (÷2 for trend, P < 0.001). Lastly, nets also
had a high impact on prevalence of splenomegaly, with
a protective efficacy of 71% (39% to 87%) for children
with untreated nets and 76% (52% to 88%) for those
with treated nets.
In children without nets the prevalence of anaemia
remained relatively stable (49% to 58%) over the study
period; this was also the case for the prevalence of
parasitaemia (68% to 71%). This suggests that the
transmission rate of malaria did not change substan›
tially during the study.
Table 2 Predictors of ownership of bed nets (logistic regression analysis: final model
also included ethnic origin of child)
Variable
No (%) of children
with nets
Adjusted odd ratio
(95% CI)
÷2 test
(P value)*
Income categories (quarters of total family income):
First (lowest) 124/185 (67) Reference group
Second 130/184 (71) 1.25 (0.59 to 2.66)
Third 142/195 (73) 1.13 (0.74 to 1.72)
Fourth (highest) 163/184 (89) 2.74 (1.58 to 4.75) 8.89 (0.031)
No access to covered wells† 191/245 (78) 0.61 (0.41 to 0.90) 3.90 (0.048)
Advised neighbours to get care for their sick children:
At formal health facility 387/464 (83) 2.27 (1.38 to 3.72) 3.90 (0.048)
From traditional healer 1/3 (33) 0.12 (0.01 to 1.07) 2.97 (0.085)
Child immunised 376/447 (84) 1.92 (0.86 to 4.29) 3.38 (0.066)
Mother educated 395/500 (79) 1.59 (0.85 to 3.00) 3.15 (0.076)
CI=confidence interval. *Likelihood ratio test. †Piped clean water.
Table 3 Impact of nets on prevalence of any parasitaemia (logistic regression analysis:
final model also included stunting, no access to covered wells, and sex)
Variable
No (%) of
children with
parasitaemia
Geometric
mean for
parasite density
Adjusted odd ratio
(95% CI)
÷2 test
(P value)*
No net 132/189 (70) 4404 Reference group
Untreated net 115/233 (49) 2890 0.49 (0.24 to 1.00)
Treated net 120/326 (37) 2745 0.38 (0.23 to 0.62) 8.75 (0.013)
Use of net in past month 107/315 (34) 3291 0.53 (0.35 to 0.79) 6.69 (0.010)
Ethnic group:
Ndamba 49/136 (36) 3901 Reference group
Pogoro 76/114 (67) 3423 3.78 (1.62 to 8.87)
Hehe 42/97 (43) 4315 1.53 (0.74 to 3.16)
Other 209/409 (51) 3070 2.48 (1.27 to 4.84) 14.63 (0.002)
Age (months):
0›6 17/61 (28) 2040 Reference group
7›12 106/245 (43) 2710 3.00 (0.95 to 9.44)
13›18 114/204 (56) 4111 3.64 (1.31 to 10.14)
>18 140/248 (56) 3622 4.85 (1.57 to 14.96) 13.4 (0.004)
Religion:
Other than Muslim or
Catholic
52/127 (41) 4434 Reference group
Muslim 157/267 (59) 2967 2.40 (1.32 to 4.35)
Catholic 159/351 (45) 3404 1.54 (1.00 to 2.37) 8.85 (0.012)
CI=confidence interval. *Likelihood ratio test.
Table 4 Impact of treated bed nets on prevalence of anaemia (haemoglobin <80 g/l)
(logistic regression analysis: final model also included distance to a shop, use of net in
previous month, immunisation status, and age and sex of child)
Variable
No (%) of children
with anaemia
Adjusted odd ratio
(95% CI)
÷2 test
(P value)*
No net 103/189 (54) Reference group
Untreated nets 90/233 (39) 0.63 (0.27 to 1.46)
Treated nets 70/326 (21) 0.37 (0.19 to 0.73) 9.58 (0.008)
Stunted height (z score <−3) 109/213 (51) 2.53 (1.66 to 3.84) 12.95 (<0.001)
No access to covered wells† 87/245 (36) 1.95 (1.24 to 3.07) 7.64 (0.006)
Religion:
Other than Muslim or Catholic 40/127 (31) Reference group
Muslim 112/267 (42) 1.80 (0.97 to 3.36)
Catholic 113/351 (32) 0.96 (0.58 to 1.58) 7.31 (0.026)
Advised neighbours to get care for their
sick children at formal health facility
125/465 (27) 0.45 (0.19 to 1.11) 4.12 (0.042)
Mother educated 179/501 (36) 1.53 (0.87 to 2.68) 2.93 (0.087)
CI=confidence interval. *Likelihood ratio test. †Piped clean water.
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Discussion
These results have shown that the social marketing
approach of distributing bed nets treated with
insecticide was highly successful and resulted quickly in
more than 80% of children aged under 2 years having
access to a net. Our results suggest a good overall
impact of social marketing of treated nets on health
outcomes in the community, with an improvement of
mean haemoglobin levels (from 80 g/l to 89 g/l) and a
decline in the total proportion of children with
anaemia (from 49% to 26%), parasitaemia, or
splenomegaly. The treated nets had an apparent
individual protective efficacy of over 60% on the preva›
lence of anaemia, parasitaemia, and splenomegaly. In
this study untreated nets were also found to be protec›
tive. Overall, most of the changes occurred in the first
year of the study.
These efficacy estimates are higher than those
found in most controlled trials (see table on the BMJ ’s
website).w1›w11 May this finding be the result, therefore, of
residual confounding despite efforts to control for it?
This question is especially pertinent because our com›
parison group comprised children who did not own
nets in the same community. The tools used to
measure confounding factors such as socioeconomic
status and health seeking behaviour may not be sensi›
tive enough to allow for proper control of confound›
ing. Factors related to the dynamics of the malaria
infection and the associated disease presentation, how›
ever, may also explain this finding. Variations in trans›
mission, for example, strongly affect the estimates of
morbidity and mortality in very young children.15
Therefore at a given transmission intensity, the age of
the study participants may be crucial in determining
the level of protection. Our finding of high impact in
children under 2 years is in line with other studies that
included very young children (see website table).
Lower impact estimates than ours were observed
in a randomised study near Ifakara in a similar age
group.w11 This may be because our study covered a
larger geographical area and included study children
with a lower mean haemoglobin level (mean level in
those without nets 77 g/l in our study, 87 g/l in the
Ifakara study, t test = 3.9, P = 0.0001). Children with
more severe anaemia are probably more likely to
benefit from intervention than children with milder
anaemia.
Nets treated with insecticide distributed through a
social marketing programme rapidly and substantially
reduced the prevalence of parasitaemia and anaemia
in children aged under 2 years. This strategy has high
potential in the control of malaria in sub›Saharan
Africa.
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What is already known on this topic
Randomised controlled trials of materials treated
with insecticide have consistently shown short
term impact on malaria morbidity and mortality
Whether these benefits can still be observed when
such materials are distributed in public health
programmes is not known
What this study adds
Bed nets treated with insecticide and distributed as
part of a large scale social marketing programme
can rapidly and substantially reduce the
prevalence of malarial parasitaemia and anaemia
in very young children
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